882. Sepsis from the ID Perspective
Session: Meet-the-Professor Session: Controversies in Sepsis (but not SIRS)
Friday, October 5, 2018: 7:15 AM
Room: S 206-208
Edward Septimus, MD, FIDSA, FSHEA, Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA

Dr. Ed Septimus received his medical degree from Baylor College of Medicine in Houston in 1972. Dr. Septimus went on to complete his postgraduate training in internal medicine and infectious diseases at Baylor College of Medicine in Houston. He is board certified in both internal medicine and infectious diseases. His current position is Senior Lecturer Department of Population Medicine Harvard Medical School. Previously was VP Research and infectious diseases HCA Health Care He has served on the Board of Directors of the Infectious Diseases Society of America (IDSA) and has been on the IDSA Antimicrobial Resistance Committee, the IDSA/SHEA Antimicrobial Stewardship Work Group and the SHEA Public Policy and Governmental Affairs Committee. He was the first recipient of the IDSA Annual Clinician Award. He was awarded the John S Dunn Sr. Outstanding Teacher Award in 2010, 2011, 2013, and 2016. He also received the Clinical Excellence Award from HealthTrust in 2103. In 2011 he was appointed and elected chair of the Patient Safety Advisory Panel for the Texas Department of State Health Services. He is on the FDA Anti-Infective Drug Advisory Group and co-chaired NQF Infectious Disease Steering Committee and is co-chair of the NQF Patient Safety Steering Committee. He also holds a faculty position as Professor at Texas A&M Medical School and Professor, Distinguished Senior Fellow, School of Public Health, George Mason University. He is the chair of the Scientific Advisory Committee Center for the Study of International Public Policy and Practices at George Mason University. He is on the Board International Society for Antimicrobial Resistance and chaired the IHI Antibiotic Stewardship Project. He is the past president of the Texas Infectious Diseases Society. He has published over 100 articles and chapters.


Disclosures:

E. Septimus, None

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.